198 related articles for article (PubMed ID: 32286309)
1. Capturing the primordial Kras mutation initiating urethane carcinogenesis.
Li S; MacAlpine DM; Counter CM
Nat Commun; 2020 Apr; 11(1):1800. PubMed ID: 32286309
[TBL] [Abstract][Full Text] [Related]
2. Non-canonical genomic driver mutations of urethane carcinogenesis.
Li S; Counter CM
PLoS One; 2022; 17(4):e0267147. PubMed ID: 35482806
[TBL] [Abstract][Full Text] [Related]
3. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
[TBL] [Abstract][Full Text] [Related]
4. Decreased tumorigenesis in mice with a Kras point mutation at C118.
Huang L; Carney J; Cardona DM; Counter CM
Nat Commun; 2014 Nov; 5():5410. PubMed ID: 25394415
[TBL] [Abstract][Full Text] [Related]
5. An ultra-sensitive method to detect mutations in human
Li S; Counter CM
Small GTPases; 2022 Jan; 13(1):287-295. PubMed ID: 35658790
[TBL] [Abstract][Full Text] [Related]
6. Signaling levels mold the RAS mutation tropism of urethane.
Li S; Counter CM
Elife; 2021 May; 10():. PubMed ID: 33998997
[TBL] [Abstract][Full Text] [Related]
7. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
[TBL] [Abstract][Full Text] [Related]
8. Rare codons capacitate Kras-driven de novo tumorigenesis.
Pershing NL; Lampson BL; Belsky JA; Kaltenbrun E; MacAlpine DM; Counter CM
J Clin Invest; 2015 Jan; 125(1):222-33. PubMed ID: 25437878
[TBL] [Abstract][Full Text] [Related]
9. Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
To MD; Wong CE; Karnezis AN; Del Rosario R; Di Lauro R; Balmain A
Nat Genet; 2008 Oct; 40(10):1240-4. PubMed ID: 18758463
[TBL] [Abstract][Full Text] [Related]
10. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.
Weyandt JD; Carney JM; Pavlisko EN; Xu M; Counter CM
PLoS One; 2016; 11(12):e0167205. PubMed ID: 27911940
[TBL] [Abstract][Full Text] [Related]
11. Comparison of liver oncogenic potential among human RAS isoforms.
Chung SI; Moon H; Ju HL; Kim DY; Cho KJ; Ribback S; Dombrowski F; Calvisi DF; Ro SW
Oncotarget; 2016 Feb; 7(6):7354-66. PubMed ID: 26799184
[TBL] [Abstract][Full Text] [Related]
12. A model for RAS mutation patterns in cancers: finding the sweet spot.
Li S; Balmain A; Counter CM
Nat Rev Cancer; 2018 Dec; 18(12):767-777. PubMed ID: 30420765
[TBL] [Abstract][Full Text] [Related]
13. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA
J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation.
Regala RP; Justilien V; Walsh MP; Weems C; Khoor A; Murray NR; Fields AP
PLoS One; 2011; 6(10):e26439. PubMed ID: 22022614
[TBL] [Abstract][Full Text] [Related]
15. Kirsten Ras* oncogene: significance of its discovery in human cancer research.
Tsuchida N; Murugan AK; Grieco M
Oncotarget; 2016 Jul; 7(29):46717-46733. PubMed ID: 27102293
[TBL] [Abstract][Full Text] [Related]
16. Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains.
Dwyer-Nield LD; McQuillan J; Hill-Baskin A; Radcliffe RA; You M; Nadeau JH; Malkinson AM
Int J Cancer; 2010 Jan; 126(1):125-32. PubMed ID: 19609923
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.
Satoh H; Moriguchi T; Takai J; Ebina M; Yamamoto M
Cancer Res; 2013 Jul; 73(13):4158-68. PubMed ID: 23610445
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C.
Cannataro VL; Gaffney SG; Stender C; Zhao ZM; Philips M; Greenstein AE; Townsend JP
Oncogene; 2018 May; 37(18):2444-2455. PubMed ID: 29453361
[TBL] [Abstract][Full Text] [Related]
19. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
Huang L; Counter CM
PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
[TBL] [Abstract][Full Text] [Related]
20. Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors.
Manenti G; Trincucci G; Pettinicchio A; Amendola E; Scarfò M; Dragani TA
Oncogene; 2008 Sep; 27(43):5753-8. PubMed ID: 18560355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
